Related Content
June 23, 2014 — BG Medicine Inc. earlier this year announced the issuance of patent 8,672,857, titled “Galectin-3 and ...
June 23, 2014
April 18, 2013 — Abbott has received Conformite Europeene (CE) marking for the Architect Galectin-3 assay, a blood test ...
April 18, 2013
February 20, 2012 — BG Medicine Inc. announced positive results from its pivotal validation study for the CardioSCORE ...
February 20, 2012
August 5, 2011 — BG Medicine Inc., a company specializing in novel, biomarker-based diagnostics, will present results ...
August 05, 2011
March 25, 2011 – A new galectin-3 test, recently cleared by the U.S. Food and Drug Administration (FDA) to help assess ...
March 25, 2011Jan. 31, 2007 — BG Medicine (BGM) has announced its participation in an alliance with Merck & Co., AstraZeneca, Royal ...
January 30, 2007